Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 30 of aTYR PHARMA INC's SEC filings and found 1 ATM program and 3 shelf registrations on file for ATYR. The latest dilution event on file is ATM sales on Dec 31, 2025. Analysis updated Oct 29, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ABOSAcumen Pharmaceuticals, Inc.
HEPAHepion Pharmaceuticals, Inc.
PLURPluri Inc. Common Stock
KYNBKyntra Bio, Inc.
ESLAEstrella Immunopharma, Inc.
JSPRJasper Therapeutics, Inc.
QNTMQuantum BioPharma Ltd.
MCRBSeres Therapeutics, Inc.
AEONAEON Biopharma, Inc.
BOLTBolt Biotherapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
CNTXContext Therapeutics Inc.
ACTUActuate Therapeutics Inc
ALLRAllarity Therapeutics, Inc.
AKTXAkari Therapeutics, Plc